ArticleAmerican heart journal2022
Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk.
Article in American heart journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Congenital heart disease in pregnancy and severe maternal morbidity: a distributed data network study.Pregnancy (Hoboken, N.J.) · 2026Article
- Article
- Racial Disparities in Severe Maternal Morbidity During the COVID-19 Pandemic: Evidence from the New Jersey Integrated Population Health Data Project.Journal of racial and ethnic health disparities · 2026Article
- Pregnancy outcomes among medically complex populations with high risk of pregnancy mortality in Virginia: a retrospective observational study.BMC medicine · 2026Observational
- Postpartum Readmission for Pregnancy-Associated Thrombotic Microangiopathy Is Associated With Poor Maternal Outcomes.Journal of clinical apheresis · 2026Article
- Assessing the Role of Cardiac Disease in Severe Maternal Morbidity: A Population-Based Cohort Study.O&G open · 2026Article
- Severe Maternal Morbidity and near Miss-Events in Women with Heart Disease: Insights from a Cohort Study.Diagnostics (Basel, Switzerland) · 2025Article
- The REBECGA Registry: A Landmark in the Care of Pregnant Women with Heart Disease in Brazil.Arquivos brasileiros de cardiologia · 2025Article
- Maternal morbidity in postpartum severe preeclampsia by obstetric delivery volume.American journal of obstetrics & gynecology MFM · 2024Article
- Maternal and Pregnancy Outcomes Following Heart Transplantation in the United States.JACC. Heart failure · 2023Article
- Mode of delivery and perinatal outcomes by modified World Health Organization classification of maternal cardiovascular risk in pregnancy.American journal of obstetrics & gynecology MFM · 2023Article
- Racial and Rural-Urban Disparities in Maternal Cardiac Disease Care in North Carolina: A Call to Action.North Carolina medical journal · 2023Article
- What work-up do we need for women with congenital heart disease in the 21st century for the preparation of pregnancy?JRSM cardiovascular diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundTo compare rates of severe maternal morbidity (SMM) for pregnant patients with a cardiac diagnosis classified by the modified World Health Organization (mWHO) classification to those without a cardiac diagnosis.
methodsThis retrospective study using the 2015-2019 Nationwide Readmissions Database identified hospitalizations, comorbidities, and outcomes using diagnosis and procedure codes. The primary exposure was cardiac diagnosis, classified into low-risk (mWHO class I and II) and moderate-to-high-risk (mWHO class II/III, III, or IV). The primary outcome was SMM or death during the delivery hospitalization; secondary outcomes included cardiac-specific SMM during delivery hospitalizations and readmissions after the delivery hospitalization.
resultsA weighted national estimate of 14,995,122 delivery admissions was identified, including 46,541 (0.31%) with mWHO I-II diagnoses and 37,330 (0.25%) with mWHO II/III-IV diagnoses. Patients with mWHO II/III-IV diagnoses experienced SMM at the highest rates (22.8% vs 1.6% for no diagnosis; with adjusted relative risk (aRR) of 5.67 [95% CI: 5.36-6.00]). The risk of death was also highest for patients with mWHO II/III-IV diagnoses (0.3% vs <0.1% for no diagnosis; aRR 18.07 [95% CI: 12.25-26.66]). Elevated risk of SMM and death persisted to 11 months postpartum for those patients with mWHO II/III-IV diagnoses.
conclusionsIn this nationwide database, SMM is highest among individuals with moderate-to-severe cardiac disease based on mWHO classification. This risk persists in the year postpartum. These results can be used to enhance pregnancy counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.